BECTON DICKINSON & CO

Cross-vertical regulatory timeline · last 180 days · 40 events

BECTON DICKINSON & CO is tracked across 2 federal verticals with 40 regulatory events in the last 180 days. Every event below traces to a primary US-government source listed in the References section.

Identifiers

Activity breakdown

Timeline

  1. SEC filing 144 — BECTON DICKINSON & CO — 2026-08-11
  2. SEC filing 4 — BECTON DICKINSON & CO — 2026-07-06
  3. sec.insider.f Muhsin Bilal EVP & President Connected Care
  4. Insider grant Muhsin Bilal EVP & President Connected Care
  5. SEC filing 11-K — BECTON DICKINSON & CO — 2026-06-29
  6. SEC filing 11-K — BECTON DICKINSON & CO — 2026-06-29
  7. Form 144 notice MICHAEL FELD Officer $11.4K
  8. Insider sell Feld Michael EVP, Chief Revenue Officer $11.5K
  9. SEC filing 144 — BECTON DICKINSON & CO — 2026-06-26
  10. SEC filing 4 — BECTON DICKINSON & CO — 2026-06-26
  11. SEC filing 4 — BECTON DICKINSON & CO — 2026-06-25
  12. Form 144 notice MICHAEL GARRISON Officer $158.3K
  13. Insider sell Garrison Michael David EVP & Pres Med.Essntl&BioPharm $160.2K
  14. SEC filing 144 — BECTON DICKINSON & CO — 2026-06-24
  15. SEC filing 4 — BECTON DICKINSON & CO — 2026-06-11
  16. Form 144 notice MICHAEL GARRISON Officer $167.2K
  17. Insider sell Garrison Michael David EVP & Pres Med.Essntl&BioPharm $166.6K
  18. SEC filing 144 — BECTON DICKINSON & CO — 2026-06-10
  19. SEC filing 25-NSE — BECTON DICKINSON & CO — 2026-06-04
  20. SEC filing 4 — BECTON DICKINSON & CO — 2026-06-03
  21. Form 144 notice THOMAS POLEN Officer $406.6K
  22. Insider sell Polen Thomas E Jr Chairman, CEO and President $404.5K
  23. SEC filing 144 — BECTON DICKINSON & CO — 2026-06-01
  24. sec.insider.d Polen Thomas E Jr Chairman, CEO and President $2.55M
  25. Option exercise Polen Thomas E Jr Chairman, CEO and President $2.55M
  26. Insider grant Menziuso Peter EVP and President, BDI
  27. SEC filing CERT — BECTON DICKINSON & CO — 2026-05-21
  28. SEC filing 8-K — BECTON DICKINSON & CO — 2026-05-20
  29. SEC filing 8-A12B — BECTON DICKINSON & CO — 2026-05-20
  30. SEC filing SCHEDULE 13G/A — BECTON DICKINSON & CO — 2026-05-15
  31. SEC filing 8-K — BECTON DICKINSON & CO — 2026-05-12
  32. SEC filing 424B2 — BECTON DICKINSON & CO — 2026-05-11
  33. SEC filing FWP — BECTON DICKINSON & CO — 2026-05-11
  34. SEC filing 4 — BECTON DICKINSON & CO — 2026-05-08
  35. SEC filing 4 — BECTON DICKINSON & CO — 2026-05-08
  36. SEC filing 4 — BECTON DICKINSON & CO — 2026-05-08
  37. Insider grant Roque Vitor EVP & Chief Financial Officer
  38. Form 144 notice MICHAEL FELD Officer $11.3K
  39. FDA recall Becton Dickinson & Co. Class II
    BD identified an issue affecting certain lots of BD GasPak EZ CO2 and BD GasPak EZ Campy Gas Generating Pouch Systems, where gas generating sachets may produce carbon dioxide levels below specification.
  40. FDA recall Becton Dickinson & Co. Class II
    BD identified an issue affecting certain lots of BD GasPak EZ CO2 and BD GasPak EZ Campy Gas Generating Pouch Systems, where gas generating sachets may produce carbon dioxide levels below specification.

References

  1. SEC EDGAR filings for BECTON DICKINSON & CO · Retrieved 2026-09-16 · 38 events in window
  2. openFDA — recalls, drug labels, adverse events · Retrieved 2026-09-16 · 2 events in window